BiotechTube
Home/Qlaris Bio/Barbara Wirostko, MD, FARVO
BW

Barbara Wirostko, MD, FARVO

Chief Medical Officer and Co-founder

Qlaris Bio

Therapeutic Areas

OphthalmologyGlaucoma

Qlaris Bio Pipeline

DrugIndicationPhase
QLS-111Primary Open-Angle Glaucoma, Ocular HypertensionPhase 1

Leadership Team at Qlaris Bio

FG
Fred Guerard, Pharm.D.
President and Chief Executive Officer
KB
Kevin Bitter
Senior Vice President, Strategy and Corporate Development
MF
Michael Fautsch, PhD
Chair, Scientific Advisory Board
View full Qlaris Bio profile